Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.Maria Mironova, Maria F. Lopes‐Virella, Richard L. Klein et al.|Diabetes|2000Cited by 97
Granulomatous liver diseasesMaria Mironova, Theo Heller, Harish Gopalakrishna et al.|Hepatology Communications|2024Cited by 25
Advances and Challenges in Managing Hepatitis D Virus: Evolving StrategiesHarish Gopalakrishna, Theo Heller, Maria Mironova et al.|Current Hepatology Reports|2024Cited by 15
Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre studyMaria Mironova, Theo Heller, Harish Gopalakrishna et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 12